Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

Summary by 6ix AI

Titan Biotech Limited has filed a disclosure regarding amendments to its Memorandum and Articles of Association, specifically altering the capital clause due to an increase in authorized share capital. The authorized share capital has been raised from a specified amount to a higher amount, allowing for the creation of additional equity shares. Details of the amendments are provided in an annexure accompanying the filing.

Written by 6ix AI from the company’s filing. How 6ix writes summaries